The current PE ratio of CDMO cannot be calculated, as the latest EPS of -$2.28 is negative. The last recorded PE ratio for Avid Bioservices was 8.38 in January 2023.
The average historical PE ratio of Avid Bioservices for the last four years is 133.1. Looking back at the last four years, CDMO's PE ratio peaked in the Apr 2021 quarter at 356.75, when the price was $21.41 and the EPS was $0.06. The lowest point was in the Apr 2022 quarter, when it reached 6.47 with a price of $13.46 and an EPS of $2.08.
Maximum annual decrease: -98.19% in 2022
Year | PE ratio | Change |
---|---|---|
2024 | N/A | N/A |
2023 | N/A | N/A |
2022 | 6.47 | -98.19% |
2021 | 356.75 | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
NEOG Neogen Corp | N/A | $3.16B |
NTRA Natera Inc | N/A | $22.36B |
MYGN Myriad Genetics Inc | N/A | $1.38B |
CDMO Avid Bioservices Inc | N/A | $781.49M |
The current price to earnings ratio of CDMO cannot be determined, as its EPS of -$2.28 is negative.
The 3-year average price to earnings ratio for CDMO stock is 30.28.
The 5-year average price to earnings ratio for CDMO stock is 133.1.
Over the last four years, the Apr 2021 quarter recorded the highest quarterly PE ratio at 356.75.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.